Succinimide

Succinimide

SCHEMBL17844269

NCC(=O)O.O=C1CCC(=O)N1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Succinimide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 8/20 0.55
GLRA1 P23415 1/20 0.50
SLC6A9 P48067 1/20 0.50
OR51E2 Q9H255 1/20 0.50
DDB1 Q16531 4/20 0.37
ITGB3 P05106 2/20 0.37
ITGB1 P05556 2/20 0.37
ITGAV P06756 2/20 0.37
ITGB2 P05107 1/20 0.37
ITGA2B P08514 1/20 0.37
ITGA5 P08648 1/20 0.37
ITGB5 P18084 1/20 0.37
ITGAL P20701 1/20 0.37
ITGA4 P13612 1/20 0.33
GABRR1 P24046 1/20 0.33
AOC3 Q16853 1/20 0.32
CA9 Q16790 1/20 0.31
TSHR P16473 3/20 0.31
LMNA P02545 2/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL17336167 0.91 CRBN (0.59) CRBNGLRA1SLC6A9OR51E2DDB1
Succinimide SCHEMBL16500285 0.84 CRBN (0.48) CRBNGLRA1SLC6A9OR51E2DDB1
Succinic Acid SCHEMBL27747025 0.82 CRBN (0.58) CRBNOR51E2ITGB3ITGB1ITGAV
Succinic Acid SCHEMBL436244 0.82 CRBN (0.58) CRBNOR51E2ITGB3ITGB1ITGAV
Succinimide SCHEMBL9241351 0.82 CRBN (0.58) CRBNDDB1ITGB3ITGB1ITGAV
Succinimide SCHEMBL27595841 0.81 CRBN (0.65) CRBNDDB1ITGB3ITGB1ITGAV
Succinimide SCHEMBL6717091 0.81 CRBN (0.73) CRBNDDB1ITGB3ITGB1ITGAV
Succinimide SCHEMBL6036901 0.81 CRBN (0.73) CRBNDDB1ITGB3ITGB1ITGAV
Succinimide SCHEMBL434236 0.81 CRBN (0.73) CRBNDDB1ITGB3ITGB1ITGAV
Succinimide SCHEMBL2221415 0.80 CRBN (0.55) CRBNDDB1ITGB3ITGB1ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115887737-A Biodegradable tissue patch in organism and preparation method thereof 诺一迈尔(苏州)生命科技有限公司 2023-04-04 CN disclosed
CN-107108496-B Multifunctional hydroxyphthalimide monomer compound 帝斯曼知识产权资产管理有限公司 2021-05-28 CN disclosed
EP-3233796-B1 POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS DSM IP ASSETS BV (NL) 2020-08-26 EP disclosed
EP-3233795-B1 ALKYD RESIN COMPOSITIONS OF POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS DSM IP ASSETS BV (NL) 2020-05-13 EP disclosed
CN-107108889-B Alkyd resin composition of multifunctional hydroxyphthalimide monomer compound 帝斯曼知识产权资产管理有限公司 2020-04-21 CN disclosed
US-10189783-B2 Polyfunctional compounds DSM IP ASSETS B.V. (NL) 2019-01-29 US disclosed
US-10167365-B2 Polymer and composition DSM IP ASSETS B.V. (NL) 2019-01-01 US disclosed
US-10066053-B2 Alkyd resin compositions DSM IP ASSETS B.V. (NL) 2018-09-04 US disclosed
US-20170355672-A1 POLYFUNCTIONAL COMPOUNDS COVESTRO (NETHERLANDS) B.V. (NL) 2017-12-14 US disclosed
EP-3055340-B1 POLYMER AND COMPOSITION DSM IP ASSETS BV (NL) 2017-11-22 EP disclosed
US-20170327636-A1 ALKYD RESIN COMPOSITIONS COVESTRO (NETHERLANDS) B.V. (NL) 2017-11-16 US disclosed
EP-3233795-A1 ALKYD RESIN COMPOSITIONS OF POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS DSM IP Assets B.V. (NL) 2017-10-25 EP disclosed
EP-3233796-A1 POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS DSM IP Assets B.V. (NL) 2017-10-25 EP disclosed
CN-107108889-A The alkyd resin composition of multifunctional hydroxyphthalimide monomeric compound 帝斯曼知识产权资产管理有限公司 2017-08-29 CN disclosed
CN-107108496-A multifunctional hydroxyphthalimide monomer compound 帝斯曼知识产权资产管理有限公司 2017-08-29 CN disclosed
US-20160237213-A1 POLYMER AND COMPOSITION COVESTRO (NETHERLANDS) B.V. (NL) 2016-08-18 US disclosed
WO-2016097403-A1 POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS DSM IP ASSETS B.V. (NL) 2016-06-23 WO disclosed
WO-2016097404-A1 ALKYD RESIN COMPOSITIONS OF POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS DSM IP ASSETS B.V. (NL) 2016-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355672-A1 POLYFUNCTIONAL COMPOUNDS H1-3, H1-0, H1-2 CRBN 267/4885GLRA1 1040/4885SLC6A9 4561/4885
US-10189783-B2 Polyfunctional compounds H1-3, H1-0, H1-2 CRBN 267/4885GLRA1 1040/4885SLC6A9 4561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.